Marcio Cesar Reino Gaggini
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Marcio Cesar Reino Gaggini has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Amílcar Sabino Damazo
Research Center in Applied Morphology and Immunology (NuPMIA), Faculty of Medicine, University of Brasília (UnB), Brasília 70910-900, Brazil
1 shared publication - Cor Jesus Fernandes Fontes
Universidade Federal de Mato Grosso, Brazil
1 shared publication - Danyenne Rejane de Assis
Universidade Federal Mato Grosso, Brasil
1 shared publication - Josafá Gonçalves Barreto
Dermato‐Immunology Laboratory Federal University of Pará Marituba Pará Brazil
1 shared publication - Marcos Cesar Florian
Department of Dermatology, Paulista Medical School, Federal University of Sao Paulo, Sao Paulo, Brazil
1 shared publication
Latest Publications
- Open Access
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Revista da Sociedade Brasileira de Medicina Tropical
- Vol. 58, e01122025
Presence of Viable Bacilli in Multibacillary Leprosy After 12 Doses of Multidrug Therapy
Background: We investigated the clinical profiles of patients with multibacillary leprosy treated with at least 12 doses of multidrug therapy (MDT), in whom intact Mycobacterium leprae bacilli were identified in skin biopsies. Methods: Clinical and therapeutic characteristics of 30 patients were analyzed, and their association with bacillary integrity was assessed. Results: Leprosy reactions were commonly observed. Two-thirds of patients completed treatment within 5 years. A strong association was observed between the 12-dose regimen and the presence of intact bacilli. Conclusions: Clinical and laboratory aspects should be considered when deciding to discontinue MDT, particularly if leprosy reactions occur.
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Revista da Sociedade Brasileira de Medicina Tropical
- Vol. 58, e01122025
Open AccessPresence of Viable Bacilli in Multibacillary Leprosy After 12 Doses of Multidrug Therapy
Background: We investigated the clinical profiles of patients with multibacillary leprosy treated with at least 12 doses of multidrug therapy (MDT), in whom intact Mycobacterium leprae bacilli were identified in skin biopsies. Methods: Clinical and therapeutic characteristics of 30 patients were analyzed, and their association with bacillary integrity was assessed. Results: Leprosy reactions were commonly observed. Two-thirds of patients completed treatment within 5 years. A strong association was observed between the 12-dose regimen and the presence of intact bacilli. Conclusions: Clinical and laboratory aspects should be considered when deciding to discontinue MDT, particularly if leprosy reactions occur.